Rocio S. M.
- Country
- Spain
- Department
- Urology Department
Research Overview
Data & Insights
Has run more than one trial at 0 of 65 partner sites.
Specializations
Oncology Focus
This investigator specializes in advanced prostate cancer treatment, with particular emphasis on managing metastatic castration-resistant prostate cancer (mCRPC). Their research interests encompass innovative therapeutic approaches for patients who have undergone prior hormonal therapy and chemotherapy.
- Advanced Prostate Cancer Management
- Metastatic Disease Treatment
- Hormone-Resistant Cancer Therapy
Their expertise extends to evaluating novel treatment modalities against established therapeutic options in advanced prostate cancer care.
Therapeutic Innovation
The investigator focuses on comparing emerging treatments with established therapeutic agents such as abiraterone acetate and enzalutamide. Their work involves evaluating treatment efficacy in advanced stages of prostate cancer.
- Novel Treatment Evaluation
- Comparative Therapy Assessment
- Treatment Resistance Management
Their research encompasses survival outcomes and progression metrics in advanced prostate cancer treatments.
Clinical Outcomes
The investigator's research emphasizes treatment effectiveness measurement through key clinical endpoints including overall survival and radiographic progression-free survival in advanced prostate cancer patients.
- Survival Outcomes Research
- Disease Progression Assessment
- Treatment Response Evaluation
Their work involves sophisticated imaging and assessment protocols to evaluate treatment effectiveness in advanced cancer care.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.